Yahoo
Shenzhen - Delayed Quote CNY

Winning Health Technology Group Co., Ltd. (300253.SZ)

6.41 -0.36 (-5.32%)
At close: October 30 at 3:04:43 PM GMT+8
Chart Range Bar
Loading chart for 300253.SZ
  • Previous Close 6.77
  • Open 6.94
  • Bid 6.41 x --
  • Ask 6.42 x --
  • Day's Range 6.40 - 6.85
  • 52 Week Range 6.40 - 16.09
  • Volume 76,644,136
  • Avg. Volume 53,307,218
  • Market Cap (intraday) 14.11B
  • Beta (5Y Monthly) 0.41
  • PE Ratio (TTM) --
  • EPS (TTM) -0.17
  • Earnings Date --
  • Forward Dividend & Yield 0.02 (0.00%)
  • Ex-Dividend Date Jun 4, 2025
  • 1y Target Est 9.56

Winning Health Technology Group Co., Ltd., together with its subsidiaries, provides digital health services for medical and health institutions in China. The company offers WiNEX, a digital health platform; internet and health care; smart hospital; smart regional healthcare; and WinCloud solutions. Its solutions are used in smart hospitals, regional health, public health, medical insurance, health services, and other fields. The company is involved in general items; software development; information system operation and maintenance; investment; non-residential real estate leasing; technology development, transfer, and promotion; and medical device sale. In addition, it provides computer hardware, software, and peripherals; information technology consulting; internet data; technical consulting; and technical services. The company was formerly known as Shanghai Kingstar Winning Software Co., Ltd. and changed its name to Winning Health Technology Group Co., Ltd. in January 2016. Winning Health Technology Group Co., Ltd. was founded in 1994 and is headquartered in Shanghai, China.

www.winning.com.cn

5,570

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

300253.SZ
27.32%
SSE Composite Index (000001.SS)
9.32%

1-Year Return

300253.SZ
24.77%
SSE Composite Index (000001.SS)
9.73%

3-Year Return

300253.SZ
14.68%
SSE Composite Index (000001.SS)
19.11%

5-Year Return

300253.SZ
48.91%
SSE Composite Index (000001.SS)
1.46%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY24
Revenue 689.57M
Earnings --
Profit Margin 0.00%

Q3

FY23

Q1

FY24

Q2

FY24

Q3

FY24

0
200M
400M
600M
0.0%
1.0%
2.0%
3.0%

Analyst Insights

View More

Analyst Price Targets

8.91
9.56 Average
6.41 Current
10.20 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -16.27%

  • Return on Assets (ttm)

    -1.99%

  • Return on Equity (ttm)

    -7.16%

  • Revenue (ttm)

    2.29B

  • Net Income Avi to Common (ttm)

    -373.05M

  • Diluted EPS (ttm)

    -0.17

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.52B

  • Total Debt/Equity (mrq)

    0.44%

  • Levered Free Cash Flow (ttm)

    1.49B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: